No coin nor oath required. For personal study only.
emission control technologies to pharmaceutical production. The alliance will involve the re-development of the new series of palladiumcontaining perovskite (Pd-perovskite) catalysts, initially formulated by Hokko for high-efficiency catalytic converters, for organic chemistry applications. Reaxa intends to develop Pdperovskites for pharmaceuticals and fine chemical synthesis applications and to use these new and highly active catalysts in drug process development and scale-up. The agreement will provide Reaxa exclusive commercialisation rights for Hokko's perovskite catalyst line for use in organic chemistry outside Japan.
๐ SIMILAR VOLUMES
The oxidative carbonylation of methane to acetic acid was investigated using Pt(II) cations as the catalyst and sulfuric acid as the solvent. The reactions were carried out at 180 โข C in a sealed batch reactor containing either fuming or concentrated (96 wt%) sulfuric acid (3 ml) and PtCl 2 (20 mM)
A series of 1%Pd/WO 3 -ZrO 2 catalysts with different W/Zr ratios and calcination temperatures of WO 3 -ZrO 2 were prepared by an impregnation method. Their crystal structure, surface state, and acidity were determined using X-ray diffraction, N 2 adsorption, NH 3 temperature-programmed desorption,